VYGR
Voyager Therapeutics Inc
NASDAQ: VYGR · HEALTHCARE · BIOTECHNOLOGY
$3.73
+2.47% today
Updated 2026-04-30
Market cap
$224.69M
P/E ratio
—
P/S ratio
5.57x
EPS (TTM)
$-2.04
Dividend yield
—
52W range
$3 – $6
Volume
0.7M
Voyager Therapeutics Inc (VYGR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-5.45M | $-11.92M | $41.30M | $-42.48M | $-61.35M | $-15.89M | $48.67M | $-96.72M | $-53.52M | $-12.51M | $77.92M | $-15.31M | $-132.47M |
| Capital expenditures | $0.00 | $2.99M | $1.03M | $5.03M | $3.98M | $4.30M | $7.72M | $12.10M | $1.61M | $2.49M | $3.26M | $3.52M | $2.60M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $425000.00 | $4.03M | $6.31M | $9.24M | $15.71M | $15.64M | $14.93M | $11.32M | $9.34M | $11.15M | $14.79M | $14.79M |
| Free cash flow | $-5.45M | $-14.91M | $40.27M | $-47.51M | $-65.33M | $-20.19M | $40.95M | $-108.81M | $-55.13M | $-15.00M | $74.66M | $-18.83M | $-135.06M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $5.33M | $-5.11M | $15.33M | $39.18M | $19.44M | $12.99M | $-18.74M | — | — | — |